Adam Crystal C4 Therapeutics, Inc. (CCCC) insider trading activity

Adam Crystal is Chief Medical Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 20,097 shares of CCCC, which is worth approximately $85,412. The most recent transaction as insider was on Jan 30, 2023, when has been sold 1,301 shares (Common Stock) at a price of $7.78 per share, resulting in proceeds of $10,121. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.1K

0% 3M change

0% 12M change

Total Value Held $85,412

Adam Crystal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 30 2023	SELL Payment of exercise price or tax liability	$10,121 $7.78 p/Share	1,301 Reduced 6.08%	20,097 Common Stock
Jan 30 2023	BUY Exercise of conversion of derivative security	-	3,750 Added 14.91%	21,398 Common Stock
May 25 2022	BUY Exercise of conversion of derivative security	-	3,750 Added 16.67%	18,750 Common Stock
Jan 04 2022	SELL Open market or private sale	$481,950 $32.13 p/Share	15,000 Reduced 50.0%	15,000 Common Stock
Jan 04 2022	BUY Exercise of conversion of derivative security	$97,350 $6.49 p/Share	15,000 Added 33.33%	30,000 Common Stock
Dec 22 2021	BUY Exercise of conversion of derivative security	$32,450 $6.49 p/Share	5,000 Added 25.0%	15,000 Common Stock
Oct 08 2021	BUY Exercise of conversion of derivative security	$64,900 $6.49 p/Share	10,000 Added 50.0%	10,000 Common Stock
Oct 01 2021	SELL Open market or private sale	$677,850 $45.19 p/Share	15,000 Reduced 100.0%	0 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$74,700 $4.98 p/Share	15,000 Added 50.0%	15,000 Common Stock
Jul 29 2021	SELL Open market or private sale	$675,000 $45.0 p/Share	15,000 Reduced 100.0%	0 Common Stock
Jul 29 2021	BUY Exercise of conversion of derivative security	$74,700 $4.98 p/Share	15,000 Added 50.0%	15,000 Common Stock
Jul 01 2021	SELL Open market or private sale	$572,400 $38.16 p/Share	15,000 Reduced 100.0%	0 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$97,500 $6.5 p/Share	15,000 Added 50.0%	15,000 Common Stock
Apr 05 2021	SELL Open market or private sale	$563,700 $37.58 p/Share	15,000 Reduced 100.0%	0 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	$97,500 $6.5 p/Share	15,000 Added 50.0%	15,000 Common Stock

Also insider at

TNGX

Tango Therapeutics, Inc. Healthcare

Adam Crystal

Chief Medical Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Value

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

Operation

Value

Type

News

Receive news related to C4 Therapeutics, Inc.

Track Activities on CCCC

Account